UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation

Heart rhythm, 2017-06, Vol.14 (6), p.801-807

2017

Volltextzugriff (PDF)

Improving human cardiac organoid design using transcriptomics

Scientific reports, 2024-08, Vol.14 (1), p.20147-11, Article 20147

2024

Volltextzugriff (PDF)

Multicellular Human Cardiac Organoids Transcriptomically Model Distinct Tissue-Level Features of Adult Myocardium

International journal of molecular sciences, 2021-08, Vol.22 (16), p.8482

2021

Volltextzugriff (PDF)

Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity

Nature biomedical engineering, 2020-04, Vol.4 (4), p.446-462

2020

Volltextzugriff (PDF)

Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries

Journal of tissue engineering and regenerative medicine, 2022-09, Vol.16 (9), p.799-811

2022

Volltextzugriff (PDF)

Atrioventricular Block After Transcatheter Balloon Expandable Aortic Valve Implantation

JACC. Cardiovascular interventions, 2008-06, Vol.1 (3), p.305-309

2008

Volltextzugriff (PDF)

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation

The American heart journal, 2005-03, Vol.149 (3), p.489-496

2005

Volltextzugriff (PDF)

Developmental lineage of human pluripotent stem cell‐derived cardiac fibroblasts affects their functional phenotype

The FASEB journal, 2021-09, Vol.35 (9), p.e21799-n/a

2021

Volltextzugriff (PDF)

Decellularized heart extracellular matrix alleviates activation of hiPSC-derived cardiac fibroblasts

Bioactive materials, 2024-01, Vol.31, p.463-474

2024

Volltextzugriff (PDF)

KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1

Journal of medical genetics, 2017-06, Vol.54 (6), p.390-398

2017

Volltextzugriff (PDF)

Prognostic impact of inappropriate defibrillator shocks in a population cohort

Heart (British Cardiac Society), 2013-09, Vol.99 (17), p.1250-1255

2013

Volltextzugriff (PDF)

Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes

The New England journal of medicine, 2000-05, Vol.342 (19), p.1385-1391

2000

Volltextzugriff (PDF)

Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale

Circulation. Arrhythmia and electrophysiology, 2009-06, Vol.2 (3), p.218-224

2009

Volltextzugriff (PDF)

Comparing 14-day adhesive patch with 24-h Holter monitoring

Future cardiology, 2014-05, Vol.10 (3), p.319-322

2014

Volltextzugriff (PDF)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: Results from the North American Multidisciplinary Study

Heart rhythm, 2009-07, Vol.6 (7), p.984-992

2009

Volltextzugriff (PDF)

Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)

Heart rhythm, 2010-09, Vol.7 (9), p.1171-1177

2010

Volltextzugriff (PDF)

Statin use and recurrence of atrial fibrillation after successful cardioversion

The American heart journal, 2007-11, Vol.154 (5), p.908-913

2007

Volltextzugriff (PDF)

Benefits and expected outcomes of the Pan-Canadian Data Definitions and Quality Indicators projects

Canadian journal of cardiology, 2010-10, Vol.26 (8), p.405-406

Kerr, Charles R., Dr

2010

Volltextzugriff (PDF)

Modified Terminal Restriction Fragment Analysis for Quantifying Telomere Length Using In-gel Hybridization

Journal of visualized experiments, 2017-07 (125)

2017

Volltextzugriff (PDF)

The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients

Canadian journal of cardiology, 2016-03, Vol.32 (3), p.336-343

2016

Volltextzugriff (PDF)

Gender-Related Differences in Atrial Fibrillation

Journal of the American College of Cardiology, 2005-10, Vol.46 (7), p.1307-1308

2005

Volltextzugriff (PDF)

Cost Comparison of Ablation Versus Antiarrhythmic Drugs As First-Line Therapy for Atrial Fibrillation: An Economic Evaluation of the RAAFT Pilot Study

Journal of cardiovascular electrophysiology, 2009-01, Vol.20 (1), p.7-12

2009

Volltextzugriff (PDF)

Impact of Cardiac Resynchronization Therapy on Hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial

Circulation (New York, N.Y.), 2014-05, Vol.129 (20), p.2021-2030

2014

Volltextzugriff (PDF)

Being responsive to the times – ensuring long-term success for the Canadian Cardiovascular Society

Canadian journal of cardiology, 2009-12, Vol.25 (12), p.677-678

Kerr, Charles, Dr

2009

Volltextzugriff (PDF)

1 – 25 von 1.030

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(876)
Mit Volltextzugriff
(803)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(519)
Life Sciences & Biomedicine
(419)
Humans
(377)
Female
(197)
Male
(186)
Biological And Medical Sciences
(134)
Middle Aged
(128)
Medical Sciences
(115)
Adult
(114)
Cardiovascular System & Cardiology
(111)
Cardiac & Cardiovascular Systems
(108)
Aged
(93)
Physical Sciences
(69)
Animals
(62)
General & Internal Medicine
(53)
Medicine, General & Internal
(49)
Adolescent
(48)
Physics
(47)
Risk Factors
(47)
Social Sciences
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation

Improving human cardiac organoid design using transcriptomics

Multicellular Human Cardiac Organoids Transcriptomically Model Distinct Tissue-Level Features of Adult Myocardium

Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity

Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop

Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries

Atrioventricular Block After Transcatheter Balloon Expandable Aortic Valve Implantation

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation

Developmental lineage of human pluripotent stem cell‐derived cardiac fibroblasts affects their functional phenotype

Decellularized heart extracellular matrix alleviates activation of hiPSC-derived cardiac fibroblasts

KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1

Prognostic impact of inappropriate defibrillator shocks in a population cohort

Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes

Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale

Comparing 14-day adhesive patch with 24-h Holter monitoring

Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: Results from the North American Multidisciplinary Study

Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)

Statin use and recurrence of atrial fibrillation after successful cardioversion

Benefits and expected outcomes of the Pan-Canadian Data Definitions and Quality Indicators projects

Modified Terminal Restriction Fragment Analysis for Quantifying Telomere Length Using In-gel Hybridization

The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients

Gender-Related Differences in Atrial Fibrillation

Cost Comparison of Ablation Versus Antiarrhythmic Drugs As First-Line Therapy for Atrial Fibrillation: An Economic Evaluation of the RAAFT Pilot Study

Impact of Cardiac Resynchronization Therapy on Hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial

Being responsive to the times – ensuring long-term success for the Canadian Cardiovascular Society

Suchergebnisse filtern